Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID ‐19 pandemic-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID ‐19 pandemic

Published:2020-06-11 Issue:9 Volume:12 Page:659-667
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:Journal of Diabetes

Author:

Infante Marco¹²³^ORCID,Ricordi Camillo²³,Fabbri Andrea¹³

Affiliation:

1. Endocrine Unit, CTO Hospital ‐ ASL Roma 2, Department of Systems MedicineUniversity of Rome Tor Vergata Rome Italy

2. Diabetes Research Institute (DRI), University of Miami Miller School of Medicine Miami Florida

3. Diabetes Research Institute Federation, DRIF (Rome, Miami) Miami Florida

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1753-0407.13053

Reference86 articles.

1. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

2. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)

3. Potential Effect of Hydroxychloroquine in Diabetes Mellitus: A Systematic Review on Preclinical and Clinical Trial Studies

4. Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial

5. Real-World Clinical Effectiveness and Tolerability of Hydroxychloroquine 400 Mg in Uncontrolled Type 2 Diabetes Subjects who are not Willing to Initiate Insulin Therapy (HYQ-Real-World Study)

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy;International Journal of Molecular Sciences;2024-09-06

2. Risk factors of using late-autophagy inhibitors: Aspects to consider when combined with anticancer therapies;Biochemical Pharmacology;2024-07

3. Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects;Rheumatology Science and Practice;2024-02-29

4. COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality;Biomedicine & Pharmacotherapy;2022-07

5. Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents;Medicina;2022-04-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3